Reviewer ’s report  
Title: Prevalence and antimicrobial susceptibility of asymptomat ic bacteriuria among women 
with pelvic organ prolapse in Abakaliki, South -East Nigeria.  
 
Version: 0 Date: 18 May 2017  
 
Reviewer: Azubuike Onyebuchi  
 
Reviewer's report:   
Please  include all comments for the authors in this box rather than uploading your report as an 
attachment. Please only upload as attachments annotated versions of manuscripts, graphs, 
supporting materials or other aspects of your report which cannot be included  in a text format.  
 
Please overwrite this text when adding your comments to the authors.  
 
COMMENTS  
 P2,L24: SPSS rather old; currently IBM SPSS since 2009  
P2,L40: Sensitivity pa ttern was not captured in your conclusion  
P3L46: There should be space after superfix 10  
P4L2: Organisms should be Organism  
There was nothing on susceptibility in your introduction  
P4L58: The study is descriptive rather than analytical  
P5L5: "on the findin g the prevalence": needs to be corrected  
P5L7: add as well as bacteriological susceptibility patterns  
P5L22: why was the sample size increased to 96  
P5L32: How was urine collected to ensure clean catch  
P5L32: What type of sterile container was used  
P5,L53: Detail of sensitivity card used is needed  
P7,L33: Table 2; What is the purpose of the t - test as this finding cannot be used to determine if 
age is a risk factor.  
P7,L43: Table 3; similar to above  
P8,L45 -59: Tetracycline, Chloramphenicol, Cloxacill in, Streptomycin, Nalidixic acid, 
Augmentin,Erythromycin, Amoxicillin and Nitrofurantoin were not among the 
antibiotics used in your methodology; refer to P5,L54 -56 
P9,L56: Table 5; Proteus is both sensitive and resistant to Nalidixic acid, Gentamycin and 
Ofloxacin: How?  
P10,L1 -15: Similar to comment in P8,L45 -59 above  
P10,L14: What is the basis of comparing patients with POP and pregnant women; They are of 
different population  
P10,L18: This study is not on pregnant women  
P10,L20: This study nor the study q uoted here did not compare asymptomatic bacteriuria (AB) 
in pregnant women versus in women with POP  
P10,L32: The population for comparism are dissimilar  
P10,L40: Explaining the difference in prevalence in males versus females in not necessary for 
this work  as it is not part of this work  
P10,L43: Does it mean that VVF is a greater risk factor for AB than POP; This inference cannot 
be drawn from this study, hence the statement is not necessary  
P11,L18: What proportion of women that had AB had organisms that w ere sensitive to 
Ciprofloxacin,; What organisms were sensitive to Ciprofloxacin  
P11,L10: Most are also sensitive to commonly prescribed antibiotics  
 
Conflict of interest was not declared  
Limitation of study was not seen  
Recommendations from the study was no t available.  
 
Are the methods appropriate and well described?  
If not, please specify what is required in your comments to the authors.  
Yes 
Does the work include the necessary controls?  
If not, please specify which controls are required in your comments to the authors.  
Yes 
 
Are the conclusions drawn adequately supported by the data shown?  
If not, please explain in your comments to the authors.  
Yes 
Are you able to assess any statistics in th e manus cript or would you recommend an 
additional statistical review?  
If an additional statistical review is recommended, please speci fy what aspects require further 
assessment in your comments to the editors.  
I recommend additional statistical review  
Quality of wri tten English  
Please indicate the quality of language in the manuscript:  
Acceptable  
Declaration of competing interests  
Please complete a declaration of competing interests, considering the following questions:  
1. Have you in the past five years received reimbursements, fees, funding, or salary fr om an  
organisation that may in any way gain or lose financial ly from the publication of this 
manuscript, either now or in the future?  
2. Do you hold any stocks or shares in an organisation t hat may in any way gain or lose 
financially from the publication o f this manuscript, either now or in the future?  
3. Do you hold or are you currently applying for any patents  relating to the content of the 
manuscript?  
4. Have you received reimbursements, fees, funding, or salary from an organization that 
holds or has applied for patents relating to the content of the manuscript?  
5. Do you have any other financial competing interests?  
6. Do you have any non -financial competing interests in relation to this paper?  
If you can answer no to all of the above, write 'I declare that I have no competing interests' 
below. If your reply is yes to any, please give details below.  
 
I have no competing interest  
 
I agree to the open peer review policy of the journal. I understand that my name will be included 
on my report to the authors and, if the manuscript is accepted for publication, my named report 
including any attachments I upload will be posted on the websi te along with the authors' 
responses. I agree for my report to be made available under an Open Access Creative Commons 
CC-BY license ( http://creativecommons.org/licenses/by/4.0/ ). I understand that any comments 
which I do not wish to be included in my name d report can be included as confidential comments 
to the editors, which will not be published.  
 
I agree to the open peer review policy of the journal